0001209191-22-002601.txt : 20220107 0001209191-22-002601.hdr.sgml : 20220107 20220107202222 ACCESSION NUMBER: 0001209191-22-002601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211229 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandison Taylor CENTRAL INDEX KEY: 0001702287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 22519399 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-29 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001702287 Sandison Taylor 6310 NANCY RIDGE DR, SUITE 101 SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Common Stock 2021-12-29 4 M 0 15600 0.00 A 256231 D Restricted Stock Unit 2021-12-29 4 M 0 10000 0.00 D 2027-09-17 Common Stock 10000 12500 D Restricted Stock Unit 2021-12-29 4 M 0 5600 0.00 D 2029-01-30 Common Stock 5600 6300 D The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021. Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021. Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer. On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones. On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones. /s/ Taylor Sandison 2022-01-07